Uncovering Institutional Buying In EQT Corp (NYSE: EQT)
Currently, there are 441.60M common shares owned by the public and among those 438.26M shares have been available to trade. The company’s stock has a 5-day price change of 0.68% and 33.21% over the past three months. EQT shares are trading 14.54% year to date (YTD), with the 12-month market performance up to 10.56% higher. […]
Reassessing The Changing Outlook For Medical Properties Trust Inc (MPW)
Currently, there are 598.99M common shares owned by the public and among those 517.59M shares have been available to trade. The company’s stock has a 5-day price change of -7.06% and -11.18% over the past three months. MPW shares are trading -14.26% year to date (YTD), with the 12-month market performance down to -8.28% lower. […]
Now Is A Suitable Moment For A Long-Term Purchase Of Keycorp (NYSE: KEY)
Currently, there are 991.28M common shares owned by the public and among those 987.20M shares have been available to trade. The company’s stock has a 5-day price change of -0.10% and 15.43% over the past three months. KEY shares are trading 33.54% year to date (YTD), with the 12-month market performance up to 59.19% higher. […]
Charles Schwab Corp (NYSE: SCHW) – Suitable For Long Term Buy?
Currently, there are 1.77B common shares owned by the public and among those 1.68B shares have been available to trade. The company’s stock has a 5-day price change of 4.55% and 25.52% over the past three months. SCHW shares are trading 18.30% year to date (YTD), with the 12-month market performance up to 46.20% higher. […]
Value Hunters: Look To Aurora Innovation Inc (AUR)
Currently, there are 1.16B common shares owned by the public and among those 961.51M shares have been available to trade. The company’s stock has a 5-day price change of 12.64% and 66.22% over the past three months. AUR shares are trading 40.73% year to date (YTD), with the 12-month market performance up to 190.09% higher. […]
Why Should You Put QuantumScape Corp (NYSE: QS) On Your Portfolio?
Currently, there are 433.16M common shares owned by the public and among those 356.59M shares have been available to trade. The company’s stock has a 5-day price change of -6.34% and -19.01% over the past three months. QS shares are trading -31.94% year to date (YTD), with the 12-month market performance down to -19.56% lower. […]
Growing Through Challenges? – Ambev S.A. ADR (ABEV)
Currently, there are 15.75B common shares owned by the public and among those 15.73B shares have been available to trade. The company’s stock has a 5-day price change of -0.91% and -8.02% over the past three months. ABEV shares are trading -22.14% year to date (YTD), with the 12-month market performance down to -17.60% lower. […]
Do Johnson & Johnson (NYSE: JNJ) Fit In A Value Investing Philosophy?
Currently, there are 2.41B common shares owned by the public and among those 2.40B shares have been available to trade. The company’s stock has a 5-day price change of -0.17% and -3.37% over the past three months. JNJ shares are trading -1.26% year to date (YTD), with the 12-month market performance up to 3.11% higher. […]
KE Holdings Inc ADR (NYSE: BEKE): The Best-Of-Breed For Investing?
Currently, there are 1.16B common shares owned by the public and among those 1.15B shares have been available to trade. The company’s stock has a 5-day price change of -3.16% and 40.66% over the past three months. BEKE shares are trading 26.77% year to date (YTD), with the 12-month market performance up to 32.75% higher. […]
Fate Therapeutics Inc (FATE) Testing Investors’ Patience Right Now
Currently, there are 98.63M common shares owned by the public and among those 97.96M shares have been available to trade. The company’s stock has a 5-day price change of -11.33% and -38.15% over the past three months. FATE shares are trading -39.30% year to date (YTD), with the 12-month market performance down to -4.62% lower. […]